| Dr Brett Ryan Jackson, DMD | |
|
1868 N Hill Field Rd, Ste. 110, Layton, UT 84041-2192 | |
| (801) 774-8198 | |
| Not Available |
| Full Name | Dr Brett Ryan Jackson |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 1868 N Hill Field Rd, Layton, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184835787 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 6593716-9922 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett Ryan Jackson, DMD 1868 N Hill Field Rd, Ste. 110, Layton, UT 84041-2192 Ph: (801) 774-8198 | Dr Brett Ryan Jackson, DMD 1868 N Hill Field Rd, Ste. 110, Layton, UT 84041-2192 Ph: (801) 774-8198 |
News Archive
Stay-at-home orders caught many medical practices and health care systems off guard, leaving them ill-equipped to rapidly adopt an efficient telemedicine platform so they could keep providing time-sensitive care to non-COVID-19 patients.
Stroke remains a leading cause of death worldwide and one of the most common reasons for disability. While a wide variety of factors influence stroke outcomes, data show that avoiding readmissions and long lengths of stay among ischemic stroke patients has benefits for patients and health care systems alike.
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) helps confirm that a molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.
A new study, to be published in the Feb. 7, 2013 issue of the American Journal of Human Genetics, expands and deepens the biological and genetic links between cardiovascular disease and schizophrenia. Cardiovascular disease (CVD) is the leading cause of premature death among schizophrenia patients, who die from heart and blood vessel disorders at a rate double that of persons without the mental disorder.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that the United States Food and Drug Administration has approved Sucampo's supplemental new drug application for AMITIZA (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.
› Verified 4 days ago
Dr. Brad J Dawson, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1597 Woodland Park Dr Ste 200, Layton, UT 84041 Phone: 801-544-1940 Fax: 801-896-0645 | |
Darin Hartvigsen, Dentist Medicare: Medicare Enrolled Practice Location: 1492 W Antelope Dr, Layton, UT 84041 Phone: 801-776-6566 | |
Dr. Andrew Rasmussen Mcfarland, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1482 N 160 W, Layton, UT 84041 Phone: 954-599-2931 | |
Dr. Dayana Arreola, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 836 S Angel St Ste 100, Layton, UT 84041 Phone: 801-544-9777 | |
Dennis Dedecker, DDS, PC Dentist Medicare: Medicare Enrolled Practice Location: 2185 N 1700 W, #204, Layton, UT 84041 Phone: 801-773-9790 Fax: 801-773-9792 | |
Dr. Taylor James Metcalf, D.M.D, M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 984 N 3200 W, Layton, UT 84041 Phone: 801-547-8800 | |
Glenn A. Zeh, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1147 Rosewood Ln, Ste 1, Layton, UT 84041 Phone: 801-544-2256 |